Accelerating cancer immunotherapy discovery AI-powered Design of T-cell-Receptor-based Cancer Immunotherapies PredictIn silico predictions of therapy side-effects during pre-clinical development EngineerSuggestions for molecular modifications to prevent side-effects LearnIntegration of lab data to improve predictions over time Meet The Team Federico Paoletti CEO & CO-FOUNDER PhD in Molecular and ComputationalOncology (University of Oxford, UK) and deepexpertise in mathematical modelling andmolecular biophysics. Linkedin Andrea Mambrini CTO & CO-FOUNDER PhD in Bio-Inspired Computation (University ofBirmingham, UK) and several years of hands-onexperience building cutting-edge AI softwaretools across the space, media, automotive andmarketing industries. Linkedin Interested? Contact us using the form below. Please enable JavaScript in your browser to complete this form.Name *Email *MessageMessageSEND Email: info@exogene.co.uk Reg. Number: 12293407 Address: Exogene Limited, Internatonal House, 24 Holborn Viaduct, EC1A 2BN, London, United Kingdom